fingolimod hydrochloride has been researched along with Nerve Pain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Braden, K; Chen, Z; Doyle, TM; Jacobson, KA; Salvemini, D; Samson, WK; Stockstill, K; Tosh, DK; Wahlman, C; Yosten, GL | 1 |
| Singh, SK; Spiegel, S | 1 |
| Houkin, K; Kawabori, M; Konno, K; Seki, T; Takamiya, S; Tateno, T; Watanabe, M; Yamazaki, K | 1 |
| Donahue, RR; Doolen, S; Grachen, CM; Iannitti, T; Shaw, BC; Taylor, BK | 1 |
| Bennett, GJ; Braden, K; Chen, Z; Doyle, TM; Giancotti, LA; Harada, CM; Janes, K; Lauro, F; Lionberger, JM; Little, JW; Neumann, WL; Salvemini, D; Spiegel, S; Stockstill, K; Weng, HR; Xiao, WH; Yadav, R; Yan, X | 1 |
| Burston, JJ; Hauser, KF; Lichtman, AH; McLane, V; Selley, DE; Sim-Selley, LJ; Welch, SP; Wilkerson, JL | 1 |
| Bieberich, E; Bryant, L; Chen, C; Chen, Z; Cuzzocrea, S; Doyle, T; Esposito, E; Janes, K; Kamocki, K; Li, C; Little, JW; Neumann, WL; Nicol, G; Obeid, L; Petrache, I; Salvemini, D; Snider, A | 1 |
1 review(s) available for fingolimod hydrochloride and Nerve Pain
| Article | Year |
|---|---|
Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Topics: Bortezomib; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fingolimod Hydrochloride; Humans; Lysophospholipids; Neuralgia; Signal Transduction; Sphingosine; Triple Negative Breast Neoplasms | 2020 |
6 other study(ies) available for fingolimod hydrochloride and Nerve Pain
| Article | Year |
|---|---|
Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Topics: Adenosine A3 Receptor Antagonists; Analgesics, Opioid; Animals; Antineoplastic Agents; Bortezomib; Duloxetine Hydrochloride; Female; Fingolimod Hydrochloride; Male; Morphine; Neuralgia; Oxaliplatin; Paclitaxel; Rats; Receptor, Adenosine A3; Sex Factors; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Spinal Cord Dorsal Horn | 2020 |
FTY720 Attenuates Neuropathic Pain after Spinal Cord Injury by Decreasing Systemic and Local Inflammation in a Rat Spinal Cord Compression Model.
Topics: Animals; Female; Fingolimod Hydrochloride; Inflammation; Injections, Intraperitoneal; Neuralgia; Rats; Rats, Sprague-Dawley; Sphingosine 1 Phosphate Receptor Modulators; Spinal Cord Compression; Spinal Cord Injuries; Thoracic Vertebrae | 2020 |
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Topics: Anilides; Animals; Central Nervous System Sensitization; Disease Models, Animal; eIF-2 Kinase; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuralgia; Organophosphonates; Oxadiazoles; Pain Threshold; Peptide Fragments; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Spinal Cord; Spinal Nerve Roots; Subcellular Fractions; Thiophenes | 2018 |
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
Topics: Administration, Oral; Animals; Astrocytes; Bortezomib; Ceramides; Fingolimod Hydrochloride; Glutamates; Male; Neuralgia; Presynaptic Terminals; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingolipids; Spinal Cord | 2018 |
Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
Topics: Animals; Disease Models, Animal; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred ICR; Neuralgia; Nociceptin; Opioid Peptides; Receptors, Lysosphingolipid; Temperature | 2018 |
The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Topics: Anilides; Animals; Antineoplastic Agents, Phytogenic; Cytokines; Enzyme Activation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Indans; Lysophospholipids; Male; Neuralgia; Organophosphonates; Oxadiazoles; Paclitaxel; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazoles; Thiophenes | 2014 |